Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
DiaMedica Therapeutics
DMAC
$342M
| $312K | ﹤0.01% |
45,440
-3,333
| -7% | -$18.1K |
|
4002
Quantum-Si Incorporated
QSI
$155M
| $312K | ﹤0.01% |
221,210
-17,791
| -7% | -$25.7K |
|
4003
BOK Financial
BOKF
$8.58B
| $311K | ﹤0.01% |
2,788
-15,462
| -85% | -$1.65M |
|
|
NREF
4004
NexPoint Real Estate Finance
NREF
$320M
| $311K | ﹤0.01% |
21,907
-1,592
| -7% | -$23K |
|
4005
NRC Health Common Stock
NRC
$432M
| $310K | ﹤0.01% |
24,292
-5,143
| -17% | -$77.1K |
|
4006
Pangaea Logistics
PANL
$498M
| $309K | ﹤0.01% |
60,919
-8,986
| -13% | -$46.5K |
|
4007
Fennec Pharmaceuticals
FENC
$332M
| $309K | ﹤0.01% |
33,038
-6,967
| -17% | -$60.3K |
|
4008
Pure Cycle
PCYO
$253M
| $309K | ﹤0.01% |
27,902
-7,354
| -21% | -$76.9K |
|
4009
Norwood Financial Corp
NWFL
$370M
| $309K | ﹤0.01% |
12,138
-2,503
| -17% | -$63.9K |
|
4010
Princeton Bancorp
BPRN
$281M
| $308K | ﹤0.01% |
9,686
-1,077
| -10% | -$34.8K |
|
|
NPB
4011
Northpointe Bancshares
NPB
$605M
| $308K | ﹤0.01% |
18,030
-8,312
| -32% | -$136K |
|
4012
Getty Images
GETY
$156M
| $308K | ﹤0.01% |
155,430
-28,629
| -16% | -$53K |
|
|
FSFG
4013
DELISTED
First Savings Financial Group
FSFG
| $307K | ﹤0.01% |
9,776
-2,498
| -20% | -$67.1K |
|
|
PCG.PRX
4014
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.37B
| $307K | ﹤0.01% |
+7,787
| New | +$303K |
|
4015
Hagerty
HGTY
$1.17B
| $305K | ﹤0.01% |
25,337
-6,456
| -20% | -$71.5K |
|
|
LPRO
4016
Open Lending Corp
LPRO
| $305K | ﹤0.01% |
144,420
-27,954
| -16% | -$63.2K |
|
|
TOPT
4017
iShares Top 20 U.S. Stocks ETF
TOPT
$665M
| $305K | ﹤0.01% |
10,000
+1,014
| +11% | +$29.2K |
|
4018
Flotek Industries
FTK
$852M
| $304K | ﹤0.01% |
20,853
-3,669
| -15% | -$46.4K |
|
4019
CS Disco
LAW
$250M
| $304K | ﹤0.01% |
47,065
-11,159
| -19% | -$55.7K |
|
4020
Candel Therapeutics
CADL
$733M
| $304K | ﹤0.01% |
59,595
-8,841
| -13% | -$51.1K |
|
|
ACLX
4021
CALL
DELISTED
Arcellx
ACLX
| $304K | ﹤0.01% |
+3,700
| New | +$266K |
|
|
ACLX
4022
PUT
DELISTED
Arcellx
ACLX
| $304K | ﹤0.01% |
+3,700
| New | +$266K |
|
4023
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $303K | ﹤0.01% |
5,601
+1,201
| +27% | +$61.9K |
|
4024
Johnson Outdoors
JOUT
$491M
| $303K | ﹤0.01% |
7,505
-1,547
| -17% | -$57.7K |
|
4025
iShares Expanded Tech Sector ETF
IGM
$10B
| $302K | ﹤0.01% |
2,400
| – | – |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.